보고서 요약(국문)

개요
글로벌 펜 니들 시장은 2022년 YY억 달러에 달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
펜 니들은 플라스틱 허브에 고정된 속이 빈 바늘로 구성되어 있으며 주사 펜에 연결됩니다. 펜 니들은 다양한 길이와 직경으로 제공됩니다. 의료 전문가들은 다양한 약물을 주입하기 위해 이러한 펜 니들을 사용합니다.
당뇨병 환자는 하루에 여러 번 인슐린 주사를 맞아야 하므로 펜 니들을 흔히 사용합니다. 펜 니들은 인슐린 피하 주사를 위해 펜 주입기와 함께 사용하도록 고안되었습니다. 인슐린 펜 니들의 길이는 4mm에서 12mm까지, 직경은 29게이지에서 32게이지까지 다양합니다.
시장 동향
신제품 출시 증가
펜 니들은 매일 여러 번 인슐린 주사를 맞아야 하는 당뇨병 환자들에게 많이 사용됩니다. 펜 니들 제품의 출시 증가는 시장 성장의 중요한 동인으로 작용합니다. 또한, 많은 주요 기업들이 새로운 치료용 펜 바늘을 출시함으로써 시장 발전에 중요한 역할을 하고 있습니다.
예를 들어, 2022년 5월 로슈 당뇨병 관리(Roche Diabetes Care)는 당뇨병 환자의 인슐린 투여 과정을 더욱 부드럽고 통증 없이 만들어주는 고품질 펜 바늘인 ACCU-FINE을 출시했습니다. 이 바늘은 부드러운 삽입을 보장하는 독특한 끝부분 절단과 빠른 인슐린 흐름을 촉진하는 얇은 벽이 특징입니다.
또한, 2021년 12월 오웬 멈포드(Owen Mumford)는 가정용 펜 바늘인 Unifine Ultra를 출시했습니다. 이 제품은 환자의 복약 순응도를 높이고 주사 경험을 개선하는 데 도움이 되는 솔루션을 제공하도록 설계된 독특한 가정용 펜 바늘입니다.
더 나아가, 당뇨병 유병률 및 발병률 증가, 고령 인구 증가, 최소 침습 시술에 대한 선호도 증가와 같은 주요 성장 동력이 향후 시장 성장을 견인할 것으로 예상됩니다.

대체 약물 전달 방식 선호도 증가
펜형 주사기는 간편하고 번거로움 없는 약물 전달 방식이지만, 바늘 찔림 부상 및 감염, 고혈당, 통증 등의 위험이 있습니다. 특히 인슐린 펜 요법은 용량 조절이 어려워 일부 환자에게 고혈당을 유발하는 것으로 나타났습니다. 이러한 이유로 인슐린 자동 중단 기능과 저혈당 위험 감소 기능을 갖춘 인슐린 펌프로 당뇨병 치료 방식이 전환되고 있습니다.

세분화 분석
글로벌 펜형 주사기 시장은 제품 유형, 길이, 용도, 유통 채널 및 지역별로 세분화됩니다.
표준형 펜형 주사기는 시장 점유율의 약 51.2%를 차지했습니다.
펜형 주사기는 일반적으로 주사기처럼 피부를 꼬집을 필요 없이 정확하게 투여할 수 있습니다. 새로운 표준형 펜형 주사기 출시 증가와 기술 발전으로 인해 표준형 펜형 주사기는 향후 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다.

예를 들어, 2022년 9월 테루모(Terumo Corporation)는 정기적인 인슐린 주사나 기타 자가 투약이 필요한 환자를 위한 멸균 펜 니들인 파인글라이드(FineGlide)를 출시했습니다. 이 펜 니들은 고급 실리콘 표면 처리된 3면 초정밀 바늘로 설계되었습니다.
또한, 2020년 9월 HTL-STREFA는 주사 시 필요한 관통력을 줄여주는 더욱 얇고 짧은 혁신적인 펜 니들인 드롭렛 마이크론(Droplet Micron)을 출시했습니다.
지역 분석
북미는 전 세계 펜 니들 시장에서 상당한 점유율을 차지할 것으로 예상됩니다.
전 세계 펜 니들 시장은 북미, 유럽, 아시아 태평양, 남미, 중동 및 아프리카로 구분됩니다.
북미는 당뇨병 유병률 증가 및 당뇨병 치료 관련 의료비 지출 증가와 같은 요인으로 인해 상당한 시장 점유율을 유지해 왔으며, 이러한 추세는 예측 기간 동안 지속될 것으로 예상됩니다.

예를 들어, 미국 질병통제예방센터(CDC)의 2022년 자료에 따르면, 미국에는 약 3,730만 명의 당뇨병 환자가 있으며, 이 중 2,870만 명(성인 2,850만 명 포함)이 당뇨병 진단을 받았습니다. 따라서 당뇨병 환자에게 인슐린을 투여하기 위한 펜형 주사기 수요가 증가하고 있습니다.
또한, 2022년 캐나다 당뇨병 협회(Diabetes Canada) 보고서에 따르면, 캐나다에는 1,170만 명의 당뇨병 또는 당뇨병 전단계 환자가 있으며, 당뇨병 환자 치료에 드는 비용은 연간 300억 달러에 달합니다. 이러한 요인들로 인해 당뇨병 환자의 약물 투여를 위한 펜형 주사기 사용이 증가하고 있으며, 이는 해당 지역의 성장을 촉진하는 데 기여하고 있습니다.

COVID-19 영향 분석
COVID-19 팬데믹은 전 세계 펜형 주사기 시장에 상당한 영향을 미쳤습니다. 2020년 초 팬데믹 발생으로 인해 광범위한 봉쇄와 제한 조치가 시행되었고, 이는 전 세계적으로 정기적인 진단, 치료, 의료기기 출시 및 상담에 차질을 초래했습니다. 팬데믹 발생으로 인해 많은 제약 및 의료기기 제조 업체들이 인력 부족에 직면했고, 봉쇄 조치로 인해 직원들의 출근이 어려워졌습니다. 따라서 이러한 요인들로 인해 펜 니들 시장은 예측 기간 동안 다소 영향을 받을 것으로 예상됩니다.
경쟁 환경
시장의 주요 글로벌 업체로는 Becton, Dickinson and Company, AdvaCare Pharma, Narang Medical Ltd., Nipro Corporation, Novo Nordisk A/S, B Braun SE, Allison Medical Inc., Terumo Corporation, Owen Mumford, Trividia Health Inc. 등이 있습니다.
주요 개발 사항
• 2022년 5월, Owen Mumford Ltd.는 당뇨병 관리 솔루션 제품군을 완성하기 위해 최신 안전 펜 니들인 Unifine SafeControl을 시장 선도 브랜드인 Unifine에 추가했다고 발표했습니다.

• 2022년 2월, Gilde Healthcare는 펜형 캐뉼라, 란셋 바늘, 특수 목적 바늘 등을 생산하는 제조업체인 Europin을 인수했습니다. Europin은 당뇨병 및 호르몬 치료 분야의 자가 투약용 주사 시스템에 중점을 두고 있습니다.
보고서 구매 이유:

• 제품 유형, 길이, 적용 분야, 유통 채널 및 지역별 글로벌 펜형 바늘 시장 세분화를 시각화하고 주요 기업 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.

• 모든 세그먼트를 포함한 펜형 바늘 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석을 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일을 제공합니다.

글로벌 펜형 바늘 시장 보고서는 약 69개의 표, 70개의 그림, 185페이지 분량입니다.

2023년 목표 고객층
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Pen Needles Market reached US$ YY billion in 2022 and is expected to reach US$ YY million by 2030 growing at a CAGR of YY% during the forecast period 2023-2030.
A pen needle comprises a hollow needle fixed in a plastic hub and connects to the injection pen. Pen needles are available in different lengths and diameters. Health professionals also use these pen needles to inject different medications.
People with diabetes commonly use pen needles, as they require multiple insulin injections per day. Pen needles are intended to be used with a pen injector device for the subcutaneous injection of insulin. Insulin pen needles range from 4 millimeters to 12 mm in length, and 29 to 32 gauge in diameter.
Market Dynamics
Increasing product launches
Pen needles are frequently used by diabetics who frequently need many daily insulin injections. The increasing number of product launches for pen needles acts as a significant driver for market growth. Also, many significant companies play a major role in the advancements of the market by launching new treatment pen needles.
For instance, in May 2022, Roche Diabetes Care launched ACCU-FINE, a quality pen needle to make the process of insulin delivery smoother and virtually painless for people with diabetes. This needle features a unique tip cut to guarantee gentle insertion and a thin wall to promote quick insulin flow.
Also, in December 2021, Owen Mumford introduced the Unifine Ultra home-use pen needle. It is a one-of-a-kind home-use pen needle that is designed to offer a solution to help improve patient compliance and enhance the injection experience.
Furthermore, significant growth drivers such as the rising prevalence and incidence of diabetes, the geriatric population, and, the inclination toward minimally invasive procedures are expected to drive the market in the forecast period.
Preference for alternative modes of drug delivery
Pen needles are an easy, hassle-free mode of drug delivery but they are also associated with needlestick injuries and infections, hyperglycemia, and pain. Insulin pen therapy is seen to cause hyperglycemia in some patients, as the dose cannot be regulated. As a result, there has been a shift in diabetes treatment, from insulin pens to insulin pumps due to their ability to perform automated insulin suspension and decrease the risk of hypoglycemia.
Segment Analysis
The global pen needles market is segmented based on product type, length, application, distribution channel and region.
Standard pen needles accounted for approximately 51.2% of the market share
Pen needles generally do not require pinching of the skin for proper administration as happens in syringes. Standard pen needles are expected to hold the largest market share over the period forecast owing to increasing new standard pen needle launches and technical advancements.
For instance, in September 2022, Terumo Corporation introduced the FineGlide, a sterile pen needle for patients requiring regular insulin injections or other self-medication. This pen needle is designed as a 3-bevel super sharp needle with a high-grade silicone surface.
Additionally, in September 2020, HTL-STREFA introduced Droplet Micron which is a new and innovative pen needle that is a thinner and shorter pen needle and reduces the penetration force required for an injection.
Geographical Analysis
North America is expected to hold a significant position in the global pen needles market share
The global pen needles market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa.
North America has maintained a significant market proportion due to factors such as the rising prevalence of diabetes, and healthcare expenditure in treating diabetes, this trend is anticipated to continue throughout the forecast period.
For instance, according to the Centers for Disease Control and Prevention 2022, an estimated 37.3 million people have diabetes in the U.S. and 28.7 million people including 28.5 million adults are diagnosed with diabetes. Hence, the demand for pen needles is increased for insulin drug delivery to diabetes patients.
Additionally, according to a Diabetes Canada report published in 2022, it states that there are 11.7 million Canadians living with diabetes or prediabetes. Also, the treatment of diabetes patients costs the healthcare system $30 billion annually. Therefore, due to the above factors, the usage of pen needles by diabetic patients for drug delivery increases which helps to boost the region’s growth.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant impact on the global pen needles market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatments, device launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the pen needles market is expected to be moderately affected over the forecast period.
Competitive Landscape
The major global players in the market include Becton, Dickinson and Company, AdvaCare Pharma, Narang Medical Ltd., Nipro Corporation, Novo Nordisk A/S, B Braun SE, Allison Medical Inc., Terumo Corporation, Owen Mumford Trividia Health Inc. among others.
Key Developments
• In May 2022, in order to round up its selection of diabetes care solutions, Owen Mumford Ltd. declared that its newest safety pen needle joined the market-leading Unifine brand as Unifine SafeControl.
• In February 2022, Gilde Healthcare acquired Europin, a manufacturer that produces pen cannulas, lancet needles, and special-purpose needles with an emphasis on injectable systems for self-medication in the areas of diabetes and hormone therapy.
Why Purchase the Report?
• To visualize the global pen needles market segmentation based on product type, length, application, distribution channel and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of pen needles market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global pen needles market report would provide approximately 69 tables, 70 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

Table of Contents
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Length
3.3. Snippet by Application
3.4. Snippet by Distribution Channel
3.5. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing product launches
4.1.1.2. YY
4.1.2. Restraints
4.1.2.1. Preference for alternative modes of drug delivery
4.1.2.2. YY
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Standard Pen Needles *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Safety Pen Needles
8. By Length
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Length
8.1.2. Market Attractiveness Index, By Length
8.2. 4mm*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. 5mm
8.4. 6mm
8.5. 8mm
8.6. 10mm
8.7. 12mm
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Insulin Therapy*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Glucagon-Like Peptide-1
9.4. Growth Hormone Therapy
9.5. Others
10. By Distribution Channel
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.1.2. Market Attractiveness Index, By Distribution Channel
10.2. Retail Pharmacy*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Hospital Pharmacy
10.4. Online Pharmacy
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Length Type
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Length Type
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Length Type
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Length Type
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Length Type
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Becton, Dickinson and Company
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. AdvaCare Pharma
13.3. Narang Medical Ltd.
13.4. Nipro Corporation
13.5. Novo Nordisk A/S
13.6. B Braun SE
13.7. Allison Medical Inc.
13.8. Terumo Corporation
13.9. Owen Mumford
13.10. Trividia Health Inc.
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Becton, Dickinson and Company, 4. Key Developments, AdvaCare Pharma, Narang Medical Ltd., Nipro Corporation, Novo Nordisk A/S, B Braun SE, Allison Medical Inc., Terumo Corporation, Owen Mumford, Trividia Health Inc.

표 목록 (Tables)

List of Tables

Table 1 Global Pen Needles Market Value, By Product, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Pen Needles Market Value, By Length, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Pen Needles Market Value, By Therapy, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Pen Needles Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Pen Needles Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Pen Needles Market Value, By Product, 2023, 2027 & 2031 (US$ Million)

Table 7 Global Pen Needles Market Value, By Product, 2022-2031 (US$ Million)

Table 8 Global Pen Needles Market Value, By Length, 2023, 2027 & 2031 (US$ Million)

Table 9 Global Pen Needles Market Value, By Length, 2022-2031 (US$ Million)

Table 10 Global Pen Needles Market Value, By Therapy, 2023, 2027 & 2031 (US$ Million)

Table 11 Global Pen Needles Market Value, By Therapy, 2022-2031 (US$ Million)

Table 12 Global Pen Needles Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 13 Global Pen Needles Market Value, By End-User, 2022-2031 (US$ Million)

Table 14 Global Pen Needles Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 15 Global Pen Needles Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America Pen Needles Market Value, By Product, 2022-2031 (US$ Million)

Table 17 North America Pen Needles Market Value, By Length, 2022-2031 (US$ Million)

Table 18 North America Pen Needles Market Value, By Therapy, 2022-2031 (US$ Million)

Table 19 North America Pen Needles Market Value, By End-User, 2022-2031 (US$ Million)

Table 20 North America Pen Needles Market Value, By Country, 2022-2031 (US$ Million)

Table 21 South America Pen Needles Market Value, By Product, 2022-2031 (US$ Million)

Table 22 South America Pen Needles Market Value, By Length, 2022-2031 (US$ Million)

Table 23 South America Pen Needles Market Value, By Therapy, 2022-2031 (US$ Million)

Table 24 South America Pen Needles Market Value, By End-User, 2022-2031 (US$ Million)

Table 25 South America Pen Needles Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe Pen Needles Market Value, By Product, 2022-2031 (US$ Million)

Table 27 Europe Pen Needles Market Value, By Length, 2022-2031 (US$ Million)

Table 28 Europe Pen Needles Market Value, By Therapy, 2022-2031 (US$ Million)

Table 29 Europe Pen Needles Market Value, By End-User, 2022-2031 (US$ Million)

Table 30 Europe Pen Needles Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Asia-Pacific Pen Needles Market Value, By Product, 2022-2031 (US$ Million)

Table 32 Asia-Pacific Pen Needles Market Value, By Length, 2022-2031 (US$ Million)

Table 33 Asia-Pacific Pen Needles Market Value, By Therapy, 2022-2031 (US$ Million)

Table 34 Asia-Pacific Pen Needles Market Value, By End-User, 2022-2031 (US$ Million)

Table 35 Asia-Pacific Pen Needles Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East & Africa Pen Needles Market Value, By Product, 2022-2031 (US$ Million)

Table 37 Middle East & Africa Pen Needles Market Value, By Length, 2022-2031 (US$ Million)

Table 38 Middle East & Africa Pen Needles Market Value, By Therapy, 2022-2031 (US$ Million)

Table 39 Middle East & Africa Pen Needles Market Value, By End-User, 2022-2031 (US$ Million)

Table 40 Becton, Dickinson and Company: Overview

Table 41 Becton, Dickinson and Company: Product Portfolio

Table 42 Becton, Dickinson and Company: Key Developments

Table 43 Novo Nordisk A/S: Overview

Table 44 Novo Nordisk A/S: Product Portfolio

Table 45 Novo Nordisk A/S: Key Developments

Table 46 B. Braun Melsungen AG: Overview

Table 47 B. Braun Melsungen AG: Product Portfolio

Table 48 B. Braun Melsungen AG: Key Developments

Table 49 Owen Mumford: Overview

Table 50 Owen Mumford: Product Portfolio

Table 51 Owen Mumford: Key Developments

Table 52 Terumo Corporation: Overview

Table 53 Terumo Corporation: Product Portfolio

Table 54 Terumo Corporation: Key Developments

Table 55 Nipro Corporation: Overview

Table 56 Nipro Corporation: Product Portfolio

Table 57 Nipro Corporation: Key Developments

Table 58 Allison Medical: Overview

Table 59 Allison Medical: Product Portfolio

Table 60 Allison Medical: Key Developments

Table 61 AdvaCare Pharma: Overview

Table 62 AdvaCare Pharma: Product Portfolio

Table 63 AdvaCare Pharma: Key Developments

Table 64 Berpu Medical Technology: Overview

Table 65 Berpu Medical Technology: Product Portfolio

Table 66 Berpu Medical Technology: Key Developments

Table 67 Trividia Health: Overview

Table 68 Trividia Health: Product Portfolio

Table 69 Trividia Health: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 2 Global Pen Needles Market Share, By Product, 2023 & 2031 (%)

Figure 3 Global Pen Needles Market Share, By Length, 2023 & 2031 (%)

Figure 4 Global Pen Needles Market Share, By Therapy, 2023 & 2031 (%)

Figure 5 Global Pen Needles Market Share, By End-User, 2023 & 2031 (%)

Figure 6 Global Pen Needles Market Share, By Region, 2023 & 2031 (%)

Figure 7 Global Pen Needles Market Y-o-Y Growth, By Product, 2022-2031 (%)

Figure 8 Standard Pen Needles Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 9 Safety Pen Needles Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 10 Global Pen Needles Market Y-o-Y Growth, By Length, 2022-2031 (%)

Figure 11 4 mm Length in Global Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 12 5 mm Length in Global Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 13 6 mm Length in Global Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 14 8 mm Length in Global Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 15 10 mm Length in Global Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 16 12 mm Length in Global Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 17 Global Pen Needles Market Y-o-Y Growth, By Therapy, 2022-2031 (%)

Figure 18 Insulin Therapy in Global Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 19 Glucagon-Like Peptide-1 Therapy in Global Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 20 Growth Hormone Therapy in Global Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 21 Other Therapies Therapy in Global Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 22 Global Pen Needles Market Y-o-Y Growth, By End-User, 2022-2031 (%)

Figure 23 Hospitals End-User in Global Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 24 Diagnostic Centers End-User in Global Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 25 Ambulatory Surgery Centers End-User in Global Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 26 Others End-User in Global Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 27 Global Pen Needles Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 28 North America Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 29 Asia-Pacific Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 30 Europe Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 31 South America Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 32 Middle East and Africa Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 33 North America Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 34 North America Pen Needles Market Share, By Product, 2023 & 2031 (%)

Figure 35 North America Pen Needles Market Share, By Length, 2023 & 2031 (%)

Figure 36 North America Pen Needles Market Share, By Therapy, 2023 & 2031 (%)

Figure 37 North America Pen Needles Market Share, By End-User, 2023 & 2031 (%)

Figure 38 North America Pen Needles Market Share, By Country, 2023 & 2031 (%)

Figure 39 South America Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 40 South America Pen Needles Market Share, By Product, 2023 & 2031 (%)

Figure 41 South America Pen Needles Market Share, By Length, 2023 & 2031 (%)

Figure 42 South America Pen Needles Market Share, By Therapy, 2023 & 2031 (%)

Figure 43 South America Pen Needles Market Share, By End-User, 2023 & 2031 (%)

Figure 44 South America Pen Needles Market Share, By Country, 2023 & 2031 (%)

Figure 45 Europe Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 46 Europe Pen Needles Market Share, By Product, 2023 & 2031 (%)

Figure 47 Europe Pen Needles Market Share, By Length, 2023 & 2031 (%)

Figure 48 Europe Pen Needles Market Share, By Therapy, 2023 & 2031 (%)

Figure 49 Europe Pen Needles Market Share, By End-User, 2023 & 2031 (%)

Figure 50 Europe Pen Needles Market Share, By Country, 2023 & 2031 (%)

Figure 51 Asia-Pacific Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 52 Asia-Pacific Pen Needles Market Share, By Product, 2023 & 2031 (%)

Figure 53 Asia-Pacific Pen Needles Market Share, By Length, 2023 & 2031 (%)

Figure 54 Asia-Pacific Pen Needles Market Share, By Therapy, 2023 & 2031 (%)

Figure 55 Asia-Pacific Pen Needles Market Share, By End-User, 2023 & 2031 (%)

Figure 56 Asia-Pacific Pen Needles Market Share, By Country, 2023 & 2031 (%)

Figure 57 Middle East & Africa Pen Needles Market Value, 2022-2031 (US$ Million)

Figure 58 Middle East & Africa Pen Needles Market Share, By Product, 2023 & 2031 (%)

Figure 59 Middle East & Africa Pen Needles Market Share, By Length, 2023 & 2031 (%)

Figure 60 Middle East & Africa Pen Needles Market Share, By Therapy, 2023 & 2031 (%)

Figure 61 Middle East & Africa Pen Needles Market Share, By End-User, 2023 & 2031 (%)

Figure 62 Becton, Dickinson and Company: Financials

Figure 63 Novo Nordisk A/S: Financials

Figure 64 B. Braun Melsungen AG: Financials

Figure 65 Owen Mumford: Financials

Figure 66 Terumo Corporation: Financials

Figure 67 Nipro Corporation: Financials

Figure 68 Allison Medical: Financials

Figure 69 AdvaCare Pharma: Financials

Figure 70 Berpu Medical Technology: Financials

Figure 71 Trividia Health: Financials

글로벌 펜 니들 시장 – 2023-2030

Global Pen Needles Market - 2023-2030